[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Pharmaceuticals Market Research Reports & Industry Analysis

Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.

The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.

The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.

Publications found: 32,915
Sort by:

Metachromatic Leukodystrophy (MLD) (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Metachromatic Leukodystrophy (MLD) (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Metachromatic Leuko...

November 2021 51 pages

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Drugs in Development, 2021

US$ 2,000.00

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Mucopolysaccharidosis I - Dru...

November 2021 110 pages

Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) - Drugs in Development, 2021

US$ 2,000.00

Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Mucopolysaccharidosis II -...

November 2021 88 pages

Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) - Drugs in Development, 2021

US$ 2,000.00

Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Mucopolysaccharidosis...

November 2021 115 pages

Multiple Sclerosis (Central Nervous System) - Drugs in Development, 2021

US$ 2,500.00

Multiple Sclerosis (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Multiple Sclerosis - Drugs In Devel...

November 2021 1320 pages

Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Health...

November 2021 127 pages

Myelodysplastic Syndrome (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Myelodysplastic Syndrome (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myelodysplastic Syndrome - Drugs In Develop...

November 2021 2188 pages

Myocardial Fibrosis (Cardiovascular) - Drugs in Development, 2021

US$ 2,000.00

Myocardial Fibrosis (Cardiovascular) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myocardial Fibrosis - Drugs In Development...

November 2021 92 pages

Neurofibromatoses Type I (Von Recklinghausen’s Disease) - Drugs in Development, 2021

US$ 2,000.00

Neurofibromatoses Type I (Von Recklinghausen’s Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neurofibromatoses Type...

November 2021 256 pages

Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Drugs in Development, 2021

US$ 3,500.00

Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Drugs in Development, 2021 SUMMARY Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) pipeline Target constitutes close to 16 molecules...

November 2021 76 pages

Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or EC 2.7.10.2) - Drugs in Development, 2021

US$ 3,500.00

Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or EC 2.7.10.2) - Drugs in Development, 2021 SUMMARY According to the recently published report 'Non Receptor Tyrosine Protein Kinase TYK2 - Drugs In De...

November 2021 123 pages

Ornithine-Transcarbamylase Deficiency - Drugs in Development, 2021

US$ 2,000.00

Ornithine-Transcarbamylase Deficiency - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ornithine-Transcarbamylase Deficiency - D...

November 2021 69 pages

P2X Purinoceptor 3 (P2RX3) - Drugs in Development, 2021

US$ 3,500.00

P2X Purinoceptor 3 (P2RX3) - Drugs in Development, 2021 SUMMARY P2X Purinoceptor 3 (P2RX3) - P2X purinoceptor 3 is a protein encoded by the P2RX3 gene. It belongs to the family of purinoceptors. This...

November 2021 70 pages

Peptic Ulcers (Gastrointestinal) - Drugs in Development, 2021

US$ 2,000.00

Peptic Ulcers (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Peptic Ulcers - Drugs In Development, 2021, pr...

November 2021 77 pages

Pertussis (Whooping Cough) (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Pertussis (Whooping Cough) (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pertussis - Drugs In Developmen...

November 2021 143 pages

Progressive Supranuclear Palsy (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Progressive Supranuclear Palsy (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Progressive Supranuclea...

November 2021 136 pages

Prostate Cancer (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Prostate Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Prostate Cancer - Drugs In Development, 2021, provid...

November 2021 4131 pages

Radiodermatitis - Drugs in Development, 2021

US$ 2,000.00

Radiodermatitis - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Radiodermatitis - Drugs In Development, 2021, provides an overv...

November 2021 73 pages

RAF Proto Oncogene Serine/Threonine Protein Kinase (Proto Oncogene c RAF or RAF1 or EC 2.7.11.1) - Drugs in Development, 2021

US$ 3,500.00

RAF Proto Oncogene Serine/Threonine Protein Kinase (Proto Oncogene c RAF or RAF1 or EC 2.7.11.1) - Drugs in Development, 2021 SUMMARY RAF Proto Oncogene Serine/Threonine Protein Kinase (Proto Oncogene...

November 2021 113 pages

Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) - Drugs in Development, 2021

US$ 3,500.00

Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) - Drugs in Development, 2021 SUMMARY Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) pipeline Target constitutes close...

November 2021 40 pages

Retinal Vein Occlusion (Ophthalmology) - Drugs in Development, 2021

US$ 2,000.00

Retinal Vein Occlusion (Ophthalmology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Retinal Vein Occlusion - Drugs In Develo...

November 2021 138 pages

Short Bowel Syndrome (Gastrointestinal) - Drugs in Development, 2021

US$ 2,000.00

Short Bowel Syndrome (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Short Bowel Syndrome - Drugs In Develop...

November 2021 84 pages

Sicca Syndrome (Sjogren) (Immunology) - Drugs in Development, 2021

US$ 2,000.00

Sicca Syndrome (Sjogren) (Immunology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Sicca Syndrome - Drugs In Development, 20...

November 2021 274 pages

Small-Cell Lung Cancer (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Small-Cell Lung Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Small-Cell Lung Cancer - Drugs In Development...

November 2021 2115 pages

Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) - Drugs in Development, 2021

US$ 3,500.00

Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) - Drugs in Development, 2021 SUMMARY According to the recently published report 'Sodium And Ch...

November 2021 42 pages

Tyrosine Protein Kinase CSK (C Src Kinase or Protein Tyrosine Kinase CYL or CSK or EC 2.7.10.2) - Drugs in Development, 2021

US$ 3,500.00

Tyrosine Protein Kinase CSK (C Src Kinase or Protein Tyrosine Kinase CYL or CSK or EC 2.7.10.2) - Drugs in Development, 2021 SUMMARY Tyrosine Protein Kinase CSK (C Src Kinase or Protein Tyrosine Kinas...

November 2021 63 pages

Usher Syndrome - Drugs in Development, 2021

US$ 2,000.00

Usher Syndrome - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Usher Syndrome - Drugs In Development, 2021, provides an overvie...

November 2021 82 pages

Wilson Disease - Drugs in Development, 2021

US$ 2,000.00

Wilson Disease - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Wilson Disease - Drugs In Development, 2021, provides an overvie...

November 2021 69 pages

Wounds (Dermatology) - Drugs in Development, 2021

US$ 2,500.00

Wounds (Dermatology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Wounds - Drugs In Development, 2021, provides an overview...

November 2021 274 pages

Leading Animal Health Suppliers to Watch in 2022-Capabilities, Goals and Strategies

US$ 4,850.00

This report provides a worldwide strategic overview of the animal health market, including: Five-year forecasts for:Assessment of major U.S. and international trends with potentially significant impac...

November 2021

Leading Generic and Specialty Drug Companies to Watch in 2022-Capabilities, Goals and Strategies

US$ 9,500.00

In the dynamic and fragmented Generic and Specialty Drug industry, besieged by intense competition and rapid change of technological innovations, the ability to anticipate new product introductions an...

November 2021

Leading Pharmaceutical Companies to Watch in 2022-Capabilities, Goals and Strategies

US$ 4,500.00

This report is part of the Competitive Analysis Series prepared by LeadingMarketResearch.com to help current suppliers and potential market entrants realistically assess their financial, technological...

November 2021

Research Report on China's Anlotinib Hydrochloride Market, 2021-2025

US$ 2,600.00

Anlotinib hydrochloride is a novel small molecule multi-target tyrosine kinase inhibitor that effectively inhibits kinases like VEGFR, PDGFR, FGFR, and c-Kit with anti-tumor angiogenesis and tumor gro...

November 2021 40 pages

Research Report on China's Bicalutamide Market, 2021-2025

US$ 2,600.00

Prostate cancer is one of the common malignant tumors in men. With the development of economy, factors like increasing environmental pollution, changing lifestyle, and aging population has caused the...

November 2021 40 pages

Probiotics Dietary Supplements Market Size, Share & Trends Analysis Report By Form (Chewable & Gummies, Capsules), By End User (Adults, Geriatric), By Region, And Segment Forecasts, 2020 - 2028

US$ 5,950.00

The global probiotics dietary supplements market is expected to reach USD 7.0 billion by 2025, according to a new report by Grand ...

November 2021 112 pages

Pharmaceutical Processing Seals Market by Material (Metals, PTFE, Nitrile Rubber, Silicone, EPDM, FKM, FFKM, UHMWPE, PU), Type (O-Ring Seals, Gaskets, Lip Seals, D Seals), Application (Manufacturing Equipment), and Region - Global Forecast to 2026

US$ 3,217.50

... the pharmaceutical processing seals market. “O-rings accounted for the largest market share in pharmaceutical processing seals market.” O-rings accounted for the largest market share in the pharmaceutical processing seals market. O-rings are used in pharmaceutical equipment ...

November 2021 165 pages

U.K. Biotechnology & Pharmaceutical Services Outsourcing Market Size, Share & Trends Analysis Report By Service (Consulting, Regulatory Affairs), By End-use (Pharma, Biotech), And Segment Forecasts, 2021 - 2028

US$ 5,950.00

This report can be delivered to the clients within 48 Business Hours U.K. Biotechnology & Pharmaceutical Services Outsourcing Market Growth & Trends The U.K. biotechnology and pharmaceutical service...

November 2021 100 pages

Botanical Supplements Market Size, Share & Trends Analysis Report By Source (Herbs, Leaves, Spices, Flowers), By Form (Tablets, Liquid), By Application, By Distribution Channel, By Region, And Segment Forecasts, 2020 - 2028

US$ 5,950.00

This report can be delivered to the clients within 72 Business Hours Botanical Supplements Market Growth & Trends The global botanical supplements market size is expected to reach USD 55.18 billion...

November 2021 145 pages

Vitamin Supplements Market Size, Share & Trends Analysis Report By Type (Multivitamin, Vitamin A, Vitamin B, Vitamin C, Vitamin D, Vitamin E, Vitamin K), By Form, By Distribution Channel, And Segment Forecasts, 2021 - 2028

US$ 5,950.00

This report can be delivered to the clients within 72 Business Hours Vitamin Supplements Market Growth & Trends The global vitamin supplements market size is expected to reach USD 71.37 billion by 2...

November 2021 150 pages

Vaccines Market by Indication (Pneumococcal, Influenza, Rotavirus, Hepatitis, COVID-19), Route of Administration (Intramuscular, Subcutaneous, Oral), Type (Inactivated, Live Attenuated, Subunit Vaccines), Valence (Multivalent, Monovalent) - Global Forecast to 2028

US$ 2,922.00

Vaccines Market by Indication (Pneumococcal, Influenza, Rotavirus, Hepatitis, COVID-19), Route of Administration (Intramuscular, Subcutaneous, Oral), Type (Inactivated, Live Attenuated, Subunit Vaccin...

November 2021 229 pages

Antifungal Drugs: Technologies and Global Markets

US$ 2,750.00

This antifungal drugs report by BCC Research analyzes the global human antifungal market and assess its growth potential over the five-year period from 2016 to 2021.

November 2021 295 pages

Active Pharmaceutical Ingredients (API) Market - Global Outlook & Forecast 2021-2026

US$ 3,750.00

In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Active Pharmaceutical Ingredients Market Report The active pharmaceutical ingredients market is expected to...

November 2021 284 pages

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute...

October 2021 2145 pages

Anaplastic Astrocytoma (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Anaplastic Astrocytoma (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Anaplastic Astrocytoma - Drugs In Development...

October 2021 304 pages

Anaplastic Oligoastrocytoma (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Anaplastic Oligoastrocytoma (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Anaplastic Oligoastrocytoma - Drugs In D...

October 2021 97 pages

Ankylosing Spondylitis (Bekhterev's Disease) (Musculoskeletal) - Drugs in Development, 2021

US$ 2,000.00

Ankylosing Spondylitis (Bekhterev's Disease) (Musculoskeletal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ankylosing Spond...

October 2021 295 pages

Axial Spondyloarthritis (Musculoskeletal) - Drugs in Development, 2021

US$ 2,000.00

Axial Spondyloarthritis (Musculoskeletal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Axial Spondyloarthritis - Drugs In De...

October 2021 305 pages

Benign Prostatic Hyperplasia (Womens and Male Health) - Drugs in Development, 2021

US$ 2,000.00

Benign Prostatic Hyperplasia (Womens and Male Health) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Benign Prostatic Hyperpla...

October 2021 109 pages

Cervical Cancer (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Cervical Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cervical Cancer - Drugs In Development, 2021, provid...

October 2021 2171 pages

Filters

Search

Categories

23,450
8,492
40
23
910

Publishers

292
33
72
1
6
72
4
18
50
16
3
112
30
34
6,128
13
120
12
142
51
363
8
25
84
33
8
8
14
6
49
111
7
1
1,818
10
579
11
2,786
7
24
5,307
44
31
54
216
1,098
40
32
7
37
46
43
50
2,538
208
40
26
7
6
2
4
33
15
596
3,346
2,222
11
22
1
16
38
228
2
7
10
4
79
4
26
50
1
5
6
2
2
32
2
13
17
1
11
106
36
1
18
181
172
4
2
1
5
4
9
78
12
27
50
33
1
27
27
1
2
1
42
55
14
18
1
323
918
568
2
1
2
5
88
74
59
37
41
22
2
14
5
22
2
2

Regions

1,371
101
87
57
55
54
52
33
31
29
28
26
25
24
23
23
23
22
22
21
20
20
20
20
19
19
19
19
19
19
19
19
18
18
18
18
17
17
17
16
16
16
16
15
15
15
15
13
12
11
11
11
10
10
7
5
14
13
12
11
11
7
6
5
3
2
1
7
4
13
5
10
8
28
1,612
7
17
11
741
21
19
14
1,325
700
597
31
30
7
6
6
5
5
4
5
5
5
4
3
1
1
1
1
2
2
2
689
16
14
6
46
12
6
57
7
24,031

Price

Date

Pages

Offers

16
15
44
5
1
2